Table 1: Laboratory data, echocardiography, blood gas analysis and hemodynamic measurements between Pre and Post EPO treatment

Pre Post P value
Body weight (kg) 53.0 ± 8.4 53.1 ± 8.6 0.976
Hct, (%) 19.0 ± 2.5 32.9 ± 3.1 < 0.001
Hb, (g/dl) 6.4 ± 0.9 10.8 ± 1.0 <0.001
Serum Epo, (mIU/ml) 17.3 ± 4.5 19.3 ± 5.7 0.128
pH 7.353 ± 0.036 7.339 ± 0.039 0.125
PaO2, (Torr) 90.9 ± 14.8 90.9 ± 12.7 0.979
PaCO2, (Torr) 35.7 ± 3.7 37.5 ± 3.6 0.046
HCO3-, (mmol/l) 20.2 ± 2.4 20.2 ± 2.4 0.963
LVDd, (mm) 51.3 ± 5.0 47.7 ± 5.4 0.006
LVDs, (mm) 30.9 ± 4.6 29.5 ± 4.5 0.219
LVEF, (%) 77.6 ± 6.7 75.8 ± 7.4 0.299
Cardiac Output, (L/min) 7.97 ± 1.59 5.61 ± 1.21 < 0.001
O2 delivery, (ml/min) 663.8 ± 161.1 793.4 ± 188.5 < 0.001


Data presented are the mean value ± SD. Hct: Hematocrit; Hb: Hemoglobin, Epo: Erythropoietin, PaO2: Arterial O2, PaCO2: Arterial CO2, HCO3-: Bicarbonate ion, LVDd: Left Ventricular End-Diastolic Dimension, LVDs: Left Ventricular End-Systolic Dimension, LVEF: Left Ventricular Ejection Fraction.